Items where Salford Author is "Bakker, EY"

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Jump to: Article | Thesis
Number of items: 10.

Article

Guazzelli, A, Meysami, P, Bakker, E, Demonacos, C, Giordano, A, Krstic- Demonacos, M ORCID: https://orcid.org/0000-0002-3914-4488 and Mutti, L 2019, 'BAP1 status determines the sensitivity of malignant mesothelioma cells to gemcitabine treatment' , International Journal of Molecular Sciences, 20 (2) , p. 429.
[img]
Preview
[img]

Tian, K, Bakker, EY, Hussain, M, Guazzelli, A, Alhebshi, H, Meysami, P, Demonacos, C, Schwartz, J-M, Mutti, L and Krstic-Demonacos, M ORCID: https://orcid.org/0000-0002-3914-4488 2018, 'p53 modeling as a route to mesothelioma patients' stratification and novel therapeutic identification' , Journal of Translational Medicine, 16 (282) .
[img]
Preview
[img]

Bakker, EY, Tian, K, Mutti, L, Demonacos, C, Schwartz, J-M and Krstic-Demonacos, M ORCID: https://orcid.org/0000-0002-3914-4488 2017, 'Insight into glucocorticoid receptor signalling through interactome model analysis' , PLOS Computational Biology, 13 (11) .
[img]
Preview
[img]
Preview

Bakker, EY, Guazzelli, A, Ashtiani, F, Demonacos, C, Krstic-Demonacos, M ORCID: https://orcid.org/0000-0002-3914-4488 and Mutti, L 2017, 'Immunotherapy advances for mesothelioma treatment' , Expert Review of Anticancer Therapy, 17 (9) , pp. 799-814.
[img]
Preview
[img]

Guazzelli, A, Bakker, EY, Tian, K, Demonacos, C, Krstic- Demonacos, M ORCID: https://orcid.org/0000-0002-3914-4488 and Mutti, L 2017, 'Promising investigational drug candidates in phase I and phase II clinical trials for mesothelioma' , Expert Opinion on Investigational Drugs, 26 (8) , pp. 933-944.
[img]
Preview

Qattan, MY, Bakker, EY, Rajendran, R, Wei-Chen Chen, D, Saha, V, Liu, J, Schwartz, J, Mutti, L, Demonacos, C and Krstic- Demonacos, M ORCID: https://orcid.org/0000-0002-3914-4488 2017, 'Differential regulation of cell death pathways by the microenvironment correlates with chemoresistance and survival in leukaemia' , PLoS ONE, 12 (6) , e0178606.
[img]
Preview
[img]

Bakker, EY, Guazzelli, A, Krstic-Demonacos, M ORCID: https://orcid.org/0000-0002-3914-4488, Lisanti, MP ORCID: https://orcid.org/0000-0003-2034-1382, Sotgia, F ORCID: https://orcid.org/0000-0003-2826-4529 and Mutti, L 2017, 'Current and prospective pharmacotherapies for the treatment of pleural mesothelioma' , Expert Opinion on Orphan Drugs, 5 (6) , pp. 455-465.
[img]
Preview
[img]

Guazzelli, A, Bakker, EY, Krstic-Demonacos, M ORCID: https://orcid.org/0000-0002-3914-4488, Lisanti, MP ORCID: https://orcid.org/0000-0003-2034-1382, Sotgia, F ORCID: https://orcid.org/0000-0003-2826-4529 and Mutti, L 2017, 'Anti-CTLA-4 therapy for malignant mesothelioma' , Immunotherapy, 9 (3) , pp. 273-280.
[img]
Preview

Bakker, EY, Qattan, M, Mutti, L, Demonacos, C and Krstic- Demonacos, M ORCID: https://orcid.org/0000-0002-3914-4488 2015, 'The role of microenvironment and immunity in drug response in leukemia' , Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1863 (3) , pp. 414-426.
[img] [img]
Preview

Thesis

Bakker, EY 2017, Analysis of drug resistance and the role of the stem cell niche in leukaemia , PhD thesis, University of Salford.
[img]
Preview

This list was generated on Wed Sep 30 01:14:34 2020 UTC.